|Mechanisms of key innate immune cells in early-and late-onset preeclampsia|
I Aneman, D Pienaar, S Suvakov, TP Simic, VD Garovic, L McClements
Frontiers in immunology 11, 1864, 2020
|Risk of pre‐eclampsia in women taking metformin: a systematic review and meta‐analysis|
A Alqudah, MC McKinley, R McNally, U Graham, CJ Watson, TJ Lyons, ...
Diabetic Medicine 35 (2), 160-172, 2018
|Top notch targeting strategies in cancer: a detailed overview of recent insights and current perspectives|
G Moore, S Annett, L McClements, T Robson
Cells 9 (6), 1503, 2020
|3D Bioprinted cancer models: Revolutionizing personalized cancer therapy|
R Augustine, SN Kalva, R Ahmad, AA Zahid, S Hasan, A Nayeem, ...
Translational Oncology 14 (4), 101015, 2021
|Targeting Treatment-Resistant Breast Cancer Stem Cells with FKBPL and Its Peptide Derivative, AD-01, via the CD44 PathwayFKBPL/AD-01 Target Breast Cancer Stem Cells|
L McClements, A Yakkundi, A Papaspyropoulos, H Harrison, MP Ablett, ...
Clinical cancer research 19 (14), 3881-3893, 2013
|Can stem cells beat COVID-19: advancing stem cells and extracellular vesicles toward mainstream medicine for lung injuries associated with SARS-CoV-2 infections|
W Chrzanowski, SY Kim, L McClements
Frontiers in Bioengineering and Biotechnology, 554, 2020
|RALA-mediated delivery of FKBPL nucleic acid therapeutics|
R Bennett, A Yakkundi, HD McKeen, L McClements, TJ McKeogh, ...
Nanomedicine 10 (19), 2989-3001, 2015
|Elucidating the pathogenesis of pre-eclampsia using in vitro models of spiral uterine artery remodelling|
R McNally, A Alqudah, D Obradovic, L McClements
Current Hypertension Reports 19, 1-13, 2017
|FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4|
L McClements, S Annett, A Yakkundi, M O’Rourke, A Valentine, ...
BMC cancer 19, 1-14, 2019
|Identification of RBCK1 as a novel regulator of FKBPL: implications for tumor growth and response to tamoxifen|
C Donley, K McClelland, HD McKeen, L Nelson, A Yakkundi, PV Jithesh, ...
Oncogene 33 (26), 3441-3450, 2014
|Hypercapnic acidosis induces mitochondrial dysfunction and impairs the ability of mesenchymal stem cells to promote distal lung epithelial repair|
N Fergie, N Todd, L McClements, D McAuley, C O’Kane, ...
The FASEB Journal 33 (4), 5585, 2019
|Association of Nrf2, SOD2 and GPX1 Polymorphisms with Biomarkers of Oxidative Distress and Survival in End-Stage Renal Disease Patients|
D Jerotic, M Matic, S Suvakov, K Vucicevic, T Damjanovic, ...
Toxins 11 (7), 431, 2019
|FKBPL is a critical antiangiogenic regulator of developmental and pathological angiogenesis|
A Yakkundi, R Bennett, I Hernández-Negrete, JM Delalande, M Hanna, ...
Arteriosclerosis, thrombosis, and vascular biology 35 (4), 845-854, 2015
|The anti-migratory effects of FKBPL and its peptide derivative, AD-01: regulation of CD44 and the cytoskeletal pathway|
A Yakkundi, L McCallum, A O’Kane, H Dyer, J Worthington, HD McKeen, ...
PloS one 8 (2), e55075, 2013
|FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer|
S Annett, G Moore, A Short, A Marshall, C McCrudden, A Yakkundi, S Das, ...
British Journal of Cancer 122 (3), 361-371, 2020
|Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin-aldosterone system (RAAS) dysregulation|
R Augustine, S Abhilash, A Nayeem, SA Salam, P Augustine, P Dan, ...
Chemico-biological interactions 351, 109738, 2022
|Emerging therapeutic potential of mesenchymal stem/stromal cells in preeclampsia|
S Suvakov, C Richards, V Nikolic, T Simic, K McGrath, ...
Current hypertension reports 22, 1-13, 2020
|Stem cell-based approaches in cardiac tissue engineering: Controlling the microenvironment for autologous cells|
R Augustine, P Dan, A Hasan, IM Khalaf, P Prasad, K Ghosal, C Gentile, ...
Biomedicine & Pharmacotherapy 138, 111425, 2021
|Markers of oxidative stress and endothelial dysfunction predict haemodialysis patients survival|
S Suvakov, D Jerotic, T Damjanovic, N Milic, T Pekmezovic, T Djukic, ...
American Journal of Nephrology 50 (2), 115-125, 2019
|Extracellular vesicles from mesenchymal stromal cells for the treatment of inflammation-related conditions|
ST Ryan, E Hosseini-Beheshti, D Afrose, X Ding, B Xia, GE Grau, CB Little, ...
International Journal of Molecular Sciences 22 (6), 3023, 2021